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ABSTRACT
Objective: Maternal morbidity, either pregnancy
related or pre-existent, can become life threatening and
of such severity as to warrant termination of pregnancy
(TOP). In this situation, chances of fetal survival are
usually poor, either because of low gestational age
and/or because of the fetal effects of the maternal
condition. Examples include severe growth restriction
in pre-eclampsia and intrauterine infection due to the
very early preterm prelabour rupture of membranes.
There are very few reports on the prevalence of TOP
for maternal indication at the limits of fetal viability. We
investigated the prevalence of and indications for TOP
on maternal indication in the 10 tertiary care centres in
the Netherlands during the past decade.
Study design: We conducted a retrospective review
of the medical records of all women who underwent
TOP for maternal indications between 22 and 27
completed weeks of gestation in all 10 tertiary care
centres from 2000 to 2009.
Results: During the study period, there were
1 929 470 deliveries; 163 052 (8.4%) of these took
place in one of the 10 tertiary care centres and 177
pregnancies were terminated for severe maternal
disease, 131 for hypertensive disorders, 29 for
intrauterine infection and 17 for other reasons. The
mean gestational age at TOP was 171 days (243/7)
±10 days. No maternal deaths were recorded. The
overall perinatal mortality was 99.4%.
Conclusions: Over a 10-year period, TOP for maternal
indications was performed in 1 in 1000 deliveries in
the 10 Dutch tertiary care centres. Hypertensive
disorders comprised three-quarters of the cases.
INTRODUCTION
Indications for termination of pregnancy
(TOP) in the Netherlands can be divided
into: psychosocial reasons (unwanted preg-
nancies), genetic reasons (fetus with con-
genital abnormalities) and maternal medical
disorders including psychiatric disorders.
Under Dutch legislation, in place and
unchanged since 1981, TOP is possible up to
the gestational age where a newborn can
survive outside the womb. This is currently
considered to be 240/7 weeks for adequately
grown fetuses without lethal disorders and a
sufﬁcient amount of amniotic ﬂuid for lung
development.1 Annually, there are approxi-
mately 28 000 terminations of pregnancy
between 5 and 24 weeks in the Netherlands.
Termination for social indications up to
22 weeks is performed in clinics with a
special license. Terminations for genetic
reasons and for medical maternal reasons
are performed in obstetric units of secondary
or tertiary care centres.
In case of lethal fetal disorders such as
trisomy 18, 13 or triploidy termination is also
allowed beyond 24 weeks, provided a number
of criteria are fulﬁlled.2 These cases are
Strengths and limitations of this study
▪ This study is one of the first to estimate the inci-
dence of termination of pregnancy for maternal
indications at the limits of fetal viability. Only
two more articles on this subject have been
identified.
▪ The results of this study raise several questions
concerning policy and approach of severely sick
mothers at the limits of fetal viability. The results
should stimulate multidisciplinary discussion
and facilitate decision-making in the future.
▪ This study is a retrospective study and could
suffer from under-reporting.
▪ During the study period, a protocol concerning
active perinatal management after spontaneous
preterm birth at the limits of fetal viability in the
Netherlands was introduced. This might have
had an impact on the approach of severely sick
mothers.
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audited by a committee of the Dutch Society of
Obstetrics and Gynecology. Termination for severe fetal
disorders in case of dismal, but not necessarily lethal,
prognosis for the fetus may be excepted from legal pros-
ecution provided adherence to stringent criteria. These
cases are assessed by an expert committee appointed by
the ministries of Health and Justice. This committee
consists of an obstetrician, a paediatrician and an ethi-
cist, and is chaired by a lawyer.2 This committee reports
directly to the Attorney General, the highest legal
authority in the Netherlands. TOP beyond 24 weeks ges-
tation for life-threatening maternal conditions in com-
bination with dismal fetal prospects (eg, due to severe
growth restriction or anhydramnios) is generally not
reported, since TOP in such cases is considered inevit-
able and the only justiﬁable management option to
prevent deteriorating maternal morbidity or even mor-
tality. According to the Guideline on Late Termination
of Pregnancy of the Dutch Society of Obstetrics and
Gynecology, maternal indications that warrant TOP
include, but are not limited to: hypertensive disorders
with organ dysfunction, sepsis, severe exacerbation of
autoimmune disorder, severely deteriorating cardiac
function, transplant rejection, rapidly progressing malig-
nancies as well as life-threatening major obstetric haem-
orrhage.2 In these situations, the fetus is also
compromised either because of the gestational age and/
or because of the low estimated fetal weight.3 TOP
beyond 24 weeks’ gestation for these indications is con-
sidered to be extremely rare. The guideline on TOP
from the Dutch Society of Gynaecology and Obstetrics
states that these patients should be referred to and
treated in a tertiary care centre. TOP on maternal indi-
cation is only performed after extensive multidisciplinary
consultation.2
The literature lacks reports on the prevalence of TOP
for maternal indications at the limits of fetal viability.
The gestational age and estimated fetal weight to con-
sider ‘active perinatal management’ directed towards
survival have recently been lowered to 24 weeks and
500 g in many countries, including the Netherlands. We
aimed to investigate the prevalence of and indications
for TOP in severely sick mothers, at the limits of fetal
viability in the Netherlands between 2000 and 2009.
METHODS
We conducted a retrospective review of the medical
records of all women who had TOP for maternal indica-
tions between 22 and 27 completed weeks of gestation
in the 10 Dutch tertiary care centres from 2000 to 2009.
Cases were identiﬁed using local delivery databases. In
all cases, the fetus was judged to be non-viable, either
because of the gestational age or because of the impact
of maternal disease on the prospects for the fetus, for
example, severe growth restriction. The inclusion and
exclusion criteria are listed in table 1. Data extraction
from the original medical ﬁles was performed by the
ﬁrst or the last author (LvE and ACB) in all cases. Data
on the total number of deliveries in the 10-year period
were extracted from the Netherlands Perinatal Registry
(PRN foundation). The indication TOP for maternal
indication is not an item in this registry.4
RESULTS
In the 10-year study period, there were 1 929 470 deliver-
ies in the Netherlands of which 163 052 (8.4%) took
place in the 10 tertiary care centres.5 6 Of those, 11 474
deliveries occurred between 220/7 and 276/7 weeks of
gestation. A total of 177 (1.5%) fulﬁlled the inclusion
criteria, 172 singleton and 5 twin pregnancies. TOP was
performed for hypertensive disorders and preterm prela-
bour rupture of membranes (PPROM) with intrauterine
infection in 131 (74%) and 29 (16%) cases, respectively.
In 17 cases (9%), there was another motive to terminate
the pregnancy (ﬁgure 1).
The mean gestational age at TOP was 171 days (243/7)
±10 days. In the hypertension group, the mean gesta-
tional age was 173 days (245/7)±9.7 days as compared with
167 days (236/7)±10.1 days in the infection group and
162 days (231/7)±7 days for the other indications. The
gestational age at termination was signiﬁcantly higher in
the hypertension group (173±9.7 days) compared with
the infection group (167±10.1 days) (p=0.006). This also
applied to the hypertension group (173±9.7 days) com-
pared with the other indications (162±7.0 days)
(p<0.001).
There were no cases of maternal mortality. A total of
182 neonates were born. There was one unexpected sur-
vivor born at GA 255/7 weeks gestation with a birth
weight of 600 g. This pregnancy was terminated without
fetal heart rate monitoring for severe HELLP syndrome
using intravenous sulprostone. The child is now 4 years
old and has a normal development so far.
The number of pregnancies terminated beyond the
limit of 240/7 weeks gestation was 113 (64%). In 94 of
these cases (83%), pregnancy was terminated for a
severe hypertensive disorder. Fifteen pregnancies (13%)
were terminated for overt intrauterine infection in the
setting of PPROM and four pregnancies (3.5%) for
other indications (table 2). In cases of termination
beyond 24 weeks, a multidisciplinary team, consisting of
at least obstetricians, neonatologists and other specialists,
Table 1 Inclusion and exclusion criteria for this study
Inclusion
criteria
Gestational age 220/7–280/7
Severe maternal condition reason for
termination
Live fetus at onset of termination
No fetal monitoring
No interventions aimed at fetus
Exclusion
criteria
Gestational age ≤216/7 or ≥281/7
Fetal indication for termination
Fetal demise at onset of termination
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when indicated, discussed the intended advice for TOP
and examined alternative options before coming to a
ﬁnal advice to the parents.
Labour was induced with prostaglandins in 176
(99.4%) of the cases. In one case, dilation and evacuation
was performed after foeticide with potassium chloride.
After induction, two pregnancies were terminated by cae-
sarean section. In one case, a caesarean section was per-
formed to expedite delivery because of recurrent
eclamptic ﬁts with neurological impairment. In the other
case, a caesarean section was performed because of a
uterine rupture accompanied by a hypovolaemic shock.
In 2006, a national guideline on active perinatal and
neonatal management after spontaneous preterm birth
at the limits of fetal viability was introduced. Before
2006, active management was generally started at
26 weeks’ gestation, whereas this was lowered to
25 weeks’ gestation in the guideline. The introduction of
this guideline has had no major effect on the number of
TOP for maternal indications. Figure 2 shows the
number of TOP per year.
The incidence of TOP varied substantially between dif-
ferent centres (table 3).
Two exemplary cases:
Case 1: A nulliparous woman, with an unremarkable
history, developed severe pre-eclampsia with
progressive HELLP syndrome at a gestational age of
23 weeks and 2 days. She was admitted and was treated
with multiple intravenous antihypertensive drugs and
magnesium sulfate. Ultrasound showed an estimated
fetal weight of 480 g. She was counselled for TOP due
to the early gestational age and the progressive course
of the disease and delivered a stillborn girl of 470 g
(<p10) at 24 weeks gestation. The delivery took place
on the intensive care unit due to refractory hyperten-
sion and pulmonary oedema in the mother.
Figure 1 Flow chart patient selection. TOP, termination of pregnancy; GA, gestational age; PROM, prelabour rupture of
membranes.
Table 2 Indications for termination of pregnancy
Indication
GA <24 weeks
(%)
GA >24 weeks
(%)
Overall 64 113
Hypertensive disorders 37 (58) 94 (83)
Intrauterine infection 14 (22) 15 (13)
Other
Uterine rupture 1 (1.6) 1 (0.8)
Obstetric bleeding 3 (4.7) 2 (1.7)
Heart failure 3 (4.7) 1 (0.8)
Psychiatric disorders 3 (4.7) –
Malignancy 3 (4.7) –
GA, gestational age.
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Case 2: A woman in her fourth pregnancy was admit-
ted at a gestational age of 22 weeks. Her obstetric
history revealed dilated peripartum cardiomyopathy.
Preconceptionally, she had been strongly advised
against pregnancy. She was admitted to the ICU
because of a severely deteriorating cardiac function.
After extensive counselling by a multidisciplinary team
consisting of obstetricians, cardiologists and neonatol-
ogists, the pregnancy was terminated at 22 weeks and
4 days’ gestation. She delivered a stillborn son.
COMMENT
In the period 2000–2009, we identiﬁed 177 cases of TOP
for life-threatening maternal morbidity in the 10 tertiary
care centres in the Netherlands. Since the indication for
TOP is not speciﬁed in the Netherlands Perinatal
Registry nor in the legally required national report on
TOP, it is not possible to check our data for under-
reporting. However, because the guideline on late TOP
from the Dutch Society of Gynecology and Obstetrics
states that women should be referred to and treated in a
tertiary care centre in case of severe maternal morbidity,
we assume that we found most cases of TOP for mater-
nal indications.
We found that there was a difference in incidence of
TOP between the tertiary care centres. This may, among
others, be due to the different local interpretation on
active neonatal management at the limits of viability in a
period where thresholds for active management were
subject to gradual change (see table 3). It is possible
that some centres advised continuing the pregnancy
anticipating an intrauterine fetal demise within days.
Dutch guidelines are in place to recommend whether
or not to start active neonatal management by a neonat-
ologist in cases with spontaneous preterm labour and an
expected weight appropriate for gestational age. These
guidelines are periodically revised based on current
(inter)national practice standards. Prior to 2006, the
overall limit for active obstetric and neonatal manage-
ment was 26 weeks of gestation. After 2006, the recom-
mended limit was 25 weeks gestation, with an estimated
fetal weight of at least 500 g7 (ﬁgure 2). In the latest
guideline dated September 2010, which was introduced
after the inclusion period of this study, the recom-
mended limit is 24 weeks gestation for intubation and
ventilation and 25 weeks for cardiac resuscitation.
Estimated fetal weight limits are no longer included.8
The prospects of children born at 24–25 weeks are
nevertheless poor, even with active management. A
recent report showed that infants who received active
perinatal and neonatal management survived in 43% of
cases at 24 weeks and in 61% of cases at 25 weeks.
Severe short-term neonatal morbidity was registered in
70–80% of surviving children.9 In case of severe mater-
nal morbidity in pregnancy, the prospects for an intact
survival for the fetus are considered to be even worse
due to the combination of low gestational age and, in
most cases, severe growth restriction or fetal inﬂamma-
tory response syndrome, as well as the deleterious effects
of the underlying maternal condition, such as chronic
fetal hypoxia. In case it becomes inevitable for the
Figure 2 Number of TOP per
year. TOP, termination of
pregnancy.
Table 3 Overview of terminations per centre and policy of active fetal management in the period 2000–2009
Centre Deliveries Terminations Incidence (%)
GA at start of active
fetal management
1 19 082 47 2.46 260/7
2 15 861 33 2.08 260/7
3 18 468 27 1.46 250/7
4 13 391 19 1.41 250/7
5 14 551 18 1.23 260/7
6 11 830 9 0.76 240/7
7 16 387 9 0.54 260/7
8 19 523 6 0.30 250/7
9 19 748 5 0.25 240/7
10 14 211 4 0.28 260/7
163 052 177 – –
GA, gestational age.
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mother’s sake to terminate the pregnancy at the limits
of fetal viability, this expected extremely poor outcome
of the child does not support an active fetal/neonatal
management. A caesarean section puts the mother at
even higher short-term and long-term risks. Therefore,
termination via induction of vaginal delivery with prosta-
glandins and without fetal monitoring will often be the
safest policy.
Hypertensive disease comprised three quarters of the
cases and was the indication for termination in 83% of
the terminations beyond 24 weeks. Experts in the ﬁeld,
as well as the WHO and NICE guidelines on hyperten-
sive disorders in pregnancy, recommend that women
who develop severe pre-eclampsia at less than 23 weeks
should be counselled towards TOP.10–12 Gaugler et al
describe 26 pregnancies, complicated by pre-eclampsia
with an onset before 24 weeks gestation and managed
expectantly. The overall perinatal mortality was 82%,
with major maternal morbidity in 65% of the women.13
In 16% of overall cases and 13% of cases beyond
24 weeks, the indication for terminating pregnancy was
intrauterine infection with overt or threatening maternal
sepsis. Septic shock and maternal death have been
reported in pregnancies managed conservatively.14–16
Therefore, TOP is recommended in case of serious clin-
ical infection.15
In 9% of overall cases and 3.5% of cases beyond
24 weeks, pregnancy was terminated for other reasons.
In the international literature, papers on other reasons
for pregnancy termination for maternal indications are
scarce. One study from Australia mentions psychiatric
disorders, malignancies and cardiac disorders as the
most common maternal indications for termination
between 5 and 23 weeks gestation.17 In a recent paper
by Piel et al from four hospitals in the Parisian area cov-
ering 95 000 deliveries between 2001 and 2010, the
main reasons for terminating pregnancy for maternal
reasons between 5 and 23 weeks of gestation were (in
decreasing order of frequency): pre-eclampsia, malig-
nancies, drug addiction, AIDS, risk of suicide, psychosis,
rape, pre-existing maternal somatic or psychiatric dis-
eases, uterine bleeding or risk of uterine rupture.18
Termination for social reasons is not allowed in the
Netherlands after 240/7 weeks gestation.
What can we learn from our observations? There are
conditions where maternal health and life are compro-
mised to such a degree, while chances for healthy fetal
survival are so dismal, that TOP is inevitable. This entails
pregnancy-induced conditions such as pre-eclampsia
and HELLP syndrome, intrauterine infection and obstet-
ric haemorrhage, as well as pre-existing or coincidental
maternal conditions such as cardiac failure or malignan-
cies. Counselling towards TOP in these situations is the
result of a multidisciplinary perinatal team discussion
involving neonatologists, and a shared decision with the
mother and her partner.
We suggest that the indication for TOP becomes a man-
datory item in the Netherlands Perinatal Registry. This
will help gain insight into the prevalence of TOP for
maternal indications. Furthermore, this registration will
enable audits of these cases by a medical peer group.
CONCLUSION
(Inter)national literature on the TOP for maternal indi-
cations at the limits of fetal viability is scarce. In this
retrospective cohort, we found a prevalence of 0.1% of
TOP for maternal reasons in the 10 tertiary care centres
in the Netherlands between 2000 and 2009.
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